Italian-led Ivermectin Meta-Analysis: Is it Time to Consider the Generic Low Cost Option to Help Treat COVID-19?

Italian-led Ivermectin Meta-Analysis Is it Time to Consider the Generic Low Cost Option to Help Treat COVID-19

A group of six critical care physicians and researchers, four of who are affiliated with IRCCS San Raffaele Scientific Institute in Milan, Italy, recently conducted a meta-analysis looking into ivermectin and along the way asking a highly uncomfortable question as to whether suspect claims about safety for commonly available drugs in fact are driven by a deep-seated, intensive fear of failure among the scientific and medical community. After all, tens of billions have been invested into a particular approach and anything that gets in the way could be deemed recognition of failure. In probing the ivermectin situation, the group, including four Italians, a Russian and Spanish doctors and researcher identified over 45 clinical trials ongoing involving ivermectin investigations. In performing yet another ivermectin meta-analysis covering a total of 1323 patients randomized across seven randomized controlled trials conducted in six countries, the group identified that in fact ivermectin treatment led to a statistically significant lower mortality rate when compared to placebo. The authors argue that while in fact “ironclad evidence” represents a fundamental underpinning of modern medic...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee